{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:10:09Z","timestamp":1767625809523,"version":"3.48.0"},"reference-count":34,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Patent foramen ovale (PFO) is present in roughly one quarter of adults and is over-represented among younger patients with cryptogenic ischemic stroke. The past decade has produced compelling evidence from randomized trials showing that PFO closure is beneficial than medical therapy in preventing recurrent ischemic stroke in appropriately selected patients. Despite this, anticoagulation continues to be used when closure is not feasible, declined, contraindicated, or considered after recurrent events. The observation that some patients experience \u201cbreakthrough\u201d stroke or transient ischemic attack (TIA) despite therapeutic anticoagulation raises a critical question: why does medical therapy fail in PFO-associated stroke, and why does closure appear superior? This narrative review synthesizes the latest evidence on the pathophysiology of PFO-associated stroke, with attention to mechanisms that remain incompletely addressed by anticoagulation. It analyzes randomized trial data comparing antiplatelet therapy, anticoagulation, and transcatheter closure. It examines the role of high-risk PFO anatomical characteristics, the Risk of Paradoxical Embolism (RoPE) score, and the PFO-Associated Stroke Causal Likelihood (PASCAL) classification in understanding medical therapy failure. Additionally, the review explores whether PFO \u201ctype\u201d predicts anticoagulation failure and highlights future research directions needed to further optimize therapy. In conclusion, in appropriately selected patients with high-risk PFO features, closure provides greater stroke risk reduction than medical therapy alone, albeit with small absolute risk differences and a procedural risk of atrial fibrillation.<\/jats:p>","DOI":"10.3390\/neurolint18010011","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:53:50Z","timestamp":1767610430000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the Failure of Medical Therapy in PFO-Associated Stroke and the Benefits of Closure: A Narrative Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7730-3665","authenticated-orcid":false,"given":"Riwaj","family":"Bhagat","sequence":"first","affiliation":[{"name":"Department of Neurology, Conemaugh Memorial Medical Center, Johnstown, PA 15905, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/jama.2025.10946","article-title":"Patent foramen ovale and stroke: A review","volume":"334","author":"Kent","year":"2025","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4065\/79.1.79","article-title":"Patent foramen ovale and stroke","volume":"79","author":"Horton","year":"2004","journal-title":"Mayo Clin. Proc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ahj.2024.08.001","article-title":"The pathophysiology of patent foramen ovale and its related complications","volume":"277","author":"Shah","year":"2024","journal-title":"Am. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Kasner","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4244\/EIJ-D-18-00341","article-title":"Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: A meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data","volume":"14","author":"Giacoppo","year":"2018","journal-title":"EuroIntervention"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, W., Zhang, J., Zhang, Y., Shentu, W., Yan, S., Chen, Q., Qiao, S., and Kong, Q. (2025). Clinical research progress on pathogenesis and treatment of Patent Foramen Ovale-associated stroke. Front. Neurol., 16.","DOI":"10.3389\/fneur.2025.1512399"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kent, D.M., Saver, J.L., Kasner, S.E., Nelson, J., Wang, A.Y., Bannuru, R.R., Carroll, J.D., Chatellier, G., Derumeaux, G., and Furlan, A.J. (2023). Evaluating Therapies to Prevent Future Stroke in Patients with Patent Foramen Ovale-Related Strokes\u2014The SCOPE Study, Patient-Centered Outcomes Research Institute (PCORI).","DOI":"10.25302\/04.2023.RS.SCOPE2019001"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/STROKEAHA.123.040546","article-title":"Patent foramen ovale management for secondary stroke prevention: State-of-the-art appraisal of current evidence","volume":"55","author":"Sposato","year":"2024","journal-title":"Stroke"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.case.2021.02.008","article-title":"Low-angle patent foramen ovale (PFO): High-risk PFO morphology associated with paradoxical embolism","volume":"5","author":"Nakayama","year":"2021","journal-title":"CASE"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zhang, H., Liu, W., Ma, J., Liu, H., Li, L., Zhou, J., Wang, S., Li, S., Wang, W., and Wang, Y. (2022). Pitfalls of using imaging technique in the presence of eustachian valve or chiari network: Effects on right-to-left shunt and related influencing factors. Diagnostics, 12.","DOI":"10.3390\/diagnostics12102283"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4330\/wjc.v13.i7.204","article-title":"Large eustachian valve fostering paradoxical thromboembolism: Passive bystander or serial partner in crime?","volume":"13","author":"Onorato","year":"2021","journal-title":"World J. Cardiol."},{"key":"ref_15","first-page":"273","article-title":"Chiari network and paradoxical embolism","volume":"68","year":"2015","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.xjtc.2021.11.006","article-title":"Chiari network and patent foramen ovale associated with stroke","volume":"11","author":"Manerikar","year":"2022","journal-title":"JTCVS Tech."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","article-title":"Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: An individual participant data meta-analysis","volume":"36","author":"Kent","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: A prespecified subgroup analysis from the NAVIGATE ESUS trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e023761","DOI":"10.1136\/bmjopen-2018-023761","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: A systematic review and network meta-analysis incorporating complementary external evidence","volume":"8","author":"Mir","year":"2018","journal-title":"BMJ Open"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Pirera, E., D\u2019Anna, L., Di Raimondo, D., and Tuttolomondo, A. (2024). Direct oral anticoagulants versus aspirin for stroke prevention after embolic stroke of undetermined source: An updated Meta-Analysis of randomized controlled trials. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226730"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e004152","DOI":"10.1161\/CIRCINTERVENTIONS.117.004152","article-title":"The case for selective patent foramen ovale closure after cryptogenic stroke","volume":"11","author":"Wiktor","year":"2018","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ioannidis, S.G., and Mitsias, P.D. (2020). Patent foramen ovale in cryptogenic ischemic stroke: Direct cause, risk factor, or incidental finding?. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00567"},{"key":"ref_25","unstructured":"Forno, D., Asteggiano, R., and Parrini, I. (2025). Patent foramen ovale in patients with cryptogenic stroke: To close or not to close?. Eur. Soc. Cardiol., Available online: https:\/\/www.escardio.org\/Councils\/Council-for-Cardiology-Practice-(CCP)\/Cardiopractice\/Patent-foramen-ovale-in-patients-with-cryptogenic-stroke-to-close-or-not-to-close."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2021.20956","article-title":"Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke","volume":"326","author":"Kent","year":"2021","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: National follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs. incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/23969873241247978","article-title":"European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke","volume":"9","author":"Caso","year":"2024","journal-title":"Eur. Stroke J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/STROKEAHA.117.020322","article-title":"Cost-effectiveness of patent foramen ovale closure versus medical therapy for secondary stroke prevention","volume":"49","author":"Leppert","year":"2018","journal-title":"Stroke"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Parks, A.L., Slager, S.L., Cizik, A.M., Fang, M.C., Supiano, M.A., Katz, P.P., and Witt, D.M. (2025). The impact of anticoagulant-related bleeding on quality of life: Development of a novel measure based on perspectives from older adults. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0316796"}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/18\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:28:01Z","timestamp":1767612481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/18\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["neurolint18010011"],"URL":"https:\/\/doi.org\/10.3390\/neurolint18010011","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}